Drug intelligence / Profile preview

BioResponse-DIM

Development stage
Unknown
Lead developer
BioResponse
Modality
Small Molecules
Administration
Oral
01

Overview

BioResponse-DIM is a microencapsulated, absorption-enhanced formulation of diindolylmethane (DIM), a phytonutrient found in cruciferous vegetables. It is being evaluated as a non-surgical intervention for cervical intraepithelial neoplasia (CIN), particularly high-grade lesions (CIN 2/3). DIM acts by modulating estrogen metabolism, specifically increasing the ratio of 2-hydroxyestrone to 16-alpha-hydroxyestrone, which is associated with reduced risk of estrogen-dependent cancers. Additionally, it exhibits anti-proliferative, anti-angiogenic, and pro-apoptotic properties in HPV-transformed cervical cells. The clinical development for CIN has been led by investigators at New York Presbyterian Hospital.

Brand names
BioResponse-DIM
Other names
diindolylmethaneDIM3,3'-diindolylmethanedi indolylmethane
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)AHR (Aryl hydrocarbon receptor)CYP1A1 (Cytochrome P450 1A1)CYP1A2 (Cytochrome P450 1A2)NF-κB

Beyond the preview

Go deeper on BioResponse-DIM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioResponse-DIM.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call